BLMS Company Profile and Key Details

The stock is currently trading near its 52-week high $0.00 and $0.00. With a market capitalization of about $19.34 thousand, Bloomios, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.43). Key stats such as the average daily volume over the past year has been around 729.00 shares, trading with heavier-than-usual volume. Headquartered in Santa Barbara, CA, Bloomios, Inc. operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Michael Hill, the company employs approximately 23 people and listed since April 22, 2003. Bloomios, Inc. manufactures, markets, and distributes cannabidiol products.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Valuation shows Bloomios, Inc. trading at a premium to the broader market with a P/E of -0.0.

Our AI price prediction model suggests that Bloomios, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Bloomios, Inc. trades at a P/E ratio of -0.0, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 The P/FCF stands at -0.0, also above market averages.